Screening for prediabetes and type 2 diabetes is crucial for early detection and intervention. Prediabetes refers to a condition where blood glucose levels are higher than normal but not high enough to be classified as diabetes. It serves as a warning sign, as people with prediabetes are at a higher risk of developing type 2 diabetes and cardiovascular complications.
Screening for prediabetes and type 2 diabetes typically involves a blood test called the A1C test, fasting plasma glucose (FPG) test, or an oral glucose tolerance test (OGTT). The A1C test measures average blood glucose levels over the past two to three months, while the FPG test measures blood glucose after fasting for at least eight hours. The OGTT involves drinking a sugary solution, and blood glucose levels are measured before and two hours after consumption.
Screening is recommended for individuals with risk factors such as being overweight, having a sedentary lifestyle, a family history of diabetes, or belonging to certain ethnic groups with a higher diabetes prevalence. Additionally, women who had gestational diabetes during pregnancy should also undergo screening.
Early detection through screening allows healthcare professionals to implement lifestyle modifications, such as dietary changes and increased physical activity, to prevent or delay the progression to type 2 diabetes. Regular monitoring and follow-up screenings are essential to track glucose levels and manage the condition effectively.
Screening for prediabetes and type 2 diabetes empowers individuals to take control of their health and make necessary lifestyle changes. It serves as a valuable tool in reducing the burden of diabetes-related complications and improving overall well-being.
After posting the publication about lipid profile assessment, we received many comments and questions. Among all the questions, type 2 diabetes and the ineffectiveness of drug treatment were mentioned most often. Therefore, today we will pay attention to this particular topic, dwelling on the following points: This article was last reviewed by Svetlana Baloban, Healsens, on March 04, …
Type 2 diabetes mellitus is rising at an epidemic scale throughout the world. Up to a certain moment, DM2 develops as a latent pathology which accounts for its late diagnosis and onset of therapy. Hence, the high frequency of vascular complications, early disablement and mortality.
Мы пока работаем над сравнением цен на анализы различных лабораторий. Спасибо за интерес и оставайтесь с нами на связи!
We're working to make this feature workable. Thanks for your interest! Subscribe to be the first user and get a 10% discount
